Amcor plc Q2 FY26 Results — Earnings Call Analysis
Published 29 May 2026 | Containers and Packaging | Market Cap: ₹18.1K Cr
- The core portfolio, including 6 focus categories (healthcare, beauty and wellness, proteins, liquids, foodservice, pet care), continues to outperform the total company with stronger EBIT margins and favorable mix. - Adjusted EPS for fiscal 2026 is expected in the range of $3.98 to $4.03 per share, representing roughly 12% growth at the midpoint, driven primarily by synergy realization.
From Amcor plc's Q2 FY26 earnings-call transcript · updated 29 May 2026.
Price
₹39.25
Market Cap
₹18.1K Cr
P/E Ratio
31.2
Revenue Rank
Margin Rank
How does Amcor plc rank in Containers and Packaging?
Compare Amcor plc against every Containers and Packaging company this quarter on revenue, margins and earnings-call signals.
📊 Revenue & Sales Performance
Rank 4- →The core portfolio, including 6 focus categories (healthcare, beauty and wellness, proteins, liquids, foodservice, pet care), continues to outperform the total company with stronger EBIT margins and favorable mix.
- →Overall company volumes were down 1.5% in Q3 but showed improvement from prior quarters; core category volumes were flat or grew low to mid-single digits.
- →Emerging markets, especially Asia and Latin America, show mid-single-digit volume growth.
- →Growth synergies from the Amcor-Berry acquisition are progressing well, with $110 million annualized revenue won so far and expected to reach $280 million over 3 years.
- →Healthcare and nutrition categories, while currently weak, are expected to improve starting mid-2026.
- →Consumer demand is durable but cautious due to inflation; a low single-digit volume decline is anticipated in the second half of calendar year.
- →Synergy capture and new contract wins support revenue growth and EPS improvement going into fiscal and calendar 2027.
📈 Profitability & Margins
Rank 3- →Adjusted EPS for fiscal 2026 is expected in the range of $3.98 to $4.03 per share, representing roughly 12% growth at the midpoint, driven primarily by synergy realization.
- →Fourth quarter adjusted EPS growth is expected at approximately 20% year-over-year, reflecting near full impact of the Berry acquisition.
- →Synergy delivery is accelerating, with $77 million achieved in Q3 and $170 million for the first 9 months; expecting $270 million in synergies for fiscal 2026, ahead of the $260 million initial target.
- →Growth synergies are tracking well against a $280 million 3-year annualized revenue target; annualized revenue synergies now exceed $110 million, expected to ramp through calendar 2026.
- →EBIT margins improving in core portfolio, with synergies and favorable mix driving growth.
- →Commitment to deleveraging and strong free cash flow generation supports sustained earnings growth beyond fiscal 2026 into calendar fiscal 2027 and beyond.
🏗️ Capital Expenditure Plans
Yes- →Fiscal 2026 capital spending is expected to be in the range of $850 million to $900 million, up compared to the prior year.
- →The company is initiating migration and consolidation of select corporate functions to a new U.S. headquarters in Miami, Florida starting in 2027.
- →Switzerland and Australia will remain important parts of the corporate footprint as key hubs.
- →No specific mention of other new strategic investments or projects, but focus continues on portfolio optimization, synergy capture, and operational execution.
💰 Fundraising & Capital Structure
No information- →There is no explicit mention of plans for new fundraising through debt or equity in the provided pages.
- →The company focuses on deleveraging, targeting to reduce leverage to a 2.5 to 3x range by fiscal/calendar 2027.
- →They plan to use cash proceeds from divestitures (approximately $500 million from 6 noncore business sales) fully to reduce debt.
- →The company maintains a commitment to an investment-grade credit rating and a strong balance sheet.
- →No indications of issuing new equity or raising new debt were provided; emphasis is on free cash flow generation and debt reduction.
- →The company expects leverage at year-end around 3.4 to 3.5x but aims for improvement through synergy capture and cash flow improvement by calendar 2027.
📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Continue your research
Others in Containers and Packaging this season
- Crown Holdings, Inc. (Q2 FY26)
Crown Holdings, Inc. Q2 FY26 quarterly results analysis. Global beverage volumes grew 5% in Q1, with strong demand expected to continue despite inflationary pre
- Avery Dennison Corporation (Q2 FY26)
Avery Dennison Corporation Q2 FY26 quarterly results analysis. Expect overall sales growth in 2026 compared to 2025, particularly ramping in second half of the
- Ball Corporation (Q2 FY26)
Ball Corporation Q2 FY26 quarterly results analysis. Global shipped beverage volumes grew ~1% YoY in Q1 2026, with low single-digit growth in North America and
- Packaging Corporation of America (Q2 FY26)
Packaging Corporation of America Q2 FY26 quarterly results analysis. Legacy bookings and billings are up approximately 4.5%, indicating strong demand momentum.
Frequently Asked Questions
What were Amcor plc Q2 FY26 results?
- The core portfolio, including 6 focus categories (healthcare, beauty and wellness, proteins, liquids, foodservice, pet care), continues to outperform the total company with stronger EBIT margins and favorable mix. - Adjusted EPS for fiscal 2026 is expected in the range of $3.98 to $4.03 per share, representing roughly 12% growth at the midpoint, driven primarily by synergy realization.
What is Amcor plc share price analysis?
Amcor plc currently shows a neutral. The stock trades at a P/E of 31.2 with a market cap of $18,147. Investors should review the full earnings analysis for detailed insights.
Is Amcor plc planning capital expenditure?
- Fiscal 2026 capital spending is expected to be in the range of $850 million to $900 million, up compared to the prior year.
Keep Amcor plc on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.